Voriconazole is a type of medicine called an antifungal. It helps fight certain serious fungal infections. It works by stopping the growth of the fungus. It's often used for infections that are resistant to other antifungal drugs.
Every report comes from a Lived member, sent anonymously.
Have you tried Vfend (Voriconazole) for Aspergillosis?
Voriconazole, sold under the brand name Vfend and as a generic, is a prescription antifungal medicine for serious fungal infections, the kind that invade the lungs, blood or deeper organs rather than staying on the skin. It is approved for adults and children 2 years and older. Its best-known use is invasive aspergillosis, an infection caused by Aspergillus, a mold whose spores are common in the air. It rarely harms healthy people but can spread through the lungs and beyond in people with weakened immune systems, such as those being treated for leukemia or recovering from a bone marrow or organ transplant. Voriconazole is also approved for candidemia (a Candida yeast infection in the bloodstream) in people who do not have very low white blood cell counts, for other deep Candida infections such as those of the skin, abdomen, kidney, bladder wall and wounds, for Candida infection of the esophagus (the tube between the throat and stomach), and for infections caused by the molds Scedosporium and Fusarium when other treatment has failed or was not tolerated. It is a treatment for established infections, chosen and adjusted by a specialist team, usually after samples are sent to identify the fungus. Treatment may begin before those results are back and change once they arrive.
Fungal cells are wrapped in a membrane built with a fat-like substance called ergosterol, which plays a role similar to cholesterol in human cells. Voriconazole belongs to the azole (triazole) family of antifungals, and it blocks a fungal enzyme needed to make ergosterol. Without enough of it, the fungal membrane becomes faulty and the fungus cannot grow normally, which gives the immune system a chance to clear the infection. The same enzyme family exists in the human liver, where it breaks down many medicines. Voriconazole strongly slows some of these liver enzymes, which is why it interacts with so many other drugs. People also differ genetically in how quickly they clear voriconazole, so the same dose can produce very different blood levels from one person to the next. Fungi can become resistant, and a fungus that resists related azoles such as fluconazole may also respond less well to voriconazole.
Voriconazole comes as an intravenous (IV) infusion, as tablets and as a liquid suspension. For invasive aspergillosis and the serious mold infections, treatment starts with higher loading doses through an IV on the first day, so that useful blood levels are reached quickly. Each infusion runs over 1 to 3 hours. Once a person is improving and can take medicine by mouth, the care team often switches to tablets or liquid, usually taken twice a day. Tablets and liquid should be taken at least one hour before or one hour after a meal. The pharmacist mixes the liquid; it should be shaken before each dose, measured with the dispenser that comes with it, and thrown away after 14 days. Doses are based on the infection, body weight in children and lighter adults, liver function and other medicines, and they are often adjusted after blood-level tests. Follow the prescription for the specific form rather than converting between forms on your own.
Vision changes are the most common side effect, reported by nearly one in five adults in clinical trials. People describe blurred vision, sensitivity to light or changes in how colors look. These changes make night driving unsafe: do not drive at night while taking voriconazole, and avoid driving or hazardous work until you know how it affects you. Some people have hallucinations (seeing or hearing things that are not there), which should be reported to the care team. Nausea, vomiting, headache, fever, chills, rash and a fast heartbeat are also common. Liver irritation is common on blood tests and occasionally becomes serious. Contact the care team promptly for yellowing of the eyes or skin, itching all over, unusual tiredness, or nausea and vomiting with flu-like feelings. Call promptly, too, for a new or worsening rash or a sunburn-like reaction. Blistering or peeling skin, sores in the mouth, or a rash with trouble swallowing or breathing can signal a rare but life-threatening skin reaction and needs emergency care right away. During an IV infusion, flushing, chest tightness, breathlessness, sweating or a racing heart can start almost immediately; tell the nurse at once so the infusion can be stopped.
Because voriconazole slows the liver enzymes that clear many drugs, and because some drugs speed up its own breakdown, interactions are its most important everyday risk. It must not be combined with certain medicines, including the antibiotics rifampin and rifabutin, the seizure medicines carbamazepine and long-acting barbiturates such as phenobarbital, high-dose ritonavir (an HIV medicine), the herbal supplement St. John's wort, the transplant drug sirolimus and the antipsychotic pimozide. Others need a dose change and close monitoring, such as the transplant drugs tacrolimus and cyclosporine, the blood thinner warfarin (which then needs more frequent clotting blood tests), methadone and long-acting opioid pain medicines. Every new prescription, over-the-counter medicine and supplement should be checked with the pharmacist first. Voriconazole makes skin far more sensitive to sunlight. Avoid direct sun, sunlamps and tanning beds, and use protective clothing and sunscreen with a high sun protection factor (SPF). People with sun reactions on long-term treatment have developed skin cancers, including squamous cell carcinoma and melanoma, so regular skin checks matter and new or changing spots should be shown to a clinician. It can lengthen the QT interval (a measure of the heart's electrical recharging), which rarely leads to dangerous rhythms, mostly in seriously ill people with other risk factors. The team corrects low potassium, magnesium and calcium and reviews heart conditions and other rhythm-affecting drugs before starting. Voriconazole can also cause kidney problems and pancreatitis (inflammation of the pancreas, often felt as severe upper abdominal pain). Voriconazole can affect the adrenal glands, which make the body's own steroid hormones, and it can raise blood levels of steroid medicines taken by any route, including pills, inhalers and nasal sprays. Anyone taking voriconazole should seek care right away for signs of too little steroid hormone: marked tiredness, weakness, dizziness, nausea or abdominal pain. People also using a steroid medicine should seek care right away for signs of too much steroid effect, such as a rounded face, weight gain or easy bruising. Voriconazole contains fluorine, and over months of treatment fluoride can build up in bone, so new bone pain should be reported. Voriconazole can harm a developing baby. People who could become pregnant should use effective contraception during treatment and tell the team right away about a pregnancy.
Many people start voriconazole in the hospital, often while also being treated for cancer, a transplant or another serious illness, and finish the course at home on tablets or liquid. How long it continues depends on the infection and on recovery of the immune system. For aspergillosis it commonly runs for months; in the main trial, people typically had about 10 days of IV treatment followed by around 11 weeks of tablets or liquid. Candida bloodstream infections are treated for at least two weeks after symptoms resolve or after the last positive culture, whichever comes later. Monitoring is a regular part of treatment. Liver tests are checked at the start and at least weekly for the first month, along with kidney function and blood salts. Many centers also measure voriconazole blood levels, since levels that are too low may not control the infection and levels that are too high raise the risk of side effects. If treatment goes beyond about four weeks, vision may be checked as well. In the trial that led to its approval for aspergillosis, more people responded to voriconazole than to the older drug amphotericin B (53% compared with 32%), and more were alive at 12 weeks (71% compared with 58%). Even so, these infections are serious and outcomes depend heavily on the underlying illness. Stopping early can let the infection return, so changes should be made with the care team.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Vfend (Voriconazole), what you've noticed, or ask the community a question.